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Abstract Mallory bodies (MBs) represent keratin-rich
inclusion bodies observed in human alcoholic liver disease
and in several chronic non-alcoholic liver diseases. The
mechanism of their formation and their relationship to other
inclusion bodies such as aggresomes is incompletely under-
stood. We could induce keratin aggregates typical of MBs
in cultured clone 9 rat hepatocytes by transgenic expression
of wild-type and mutant aquaporin2 or 1-antitrypsin and
under various forms of other cellular stress. By immunocy-
tochemical analysis, p62 and poly-ubiquitin, components of
classical MBs, could be demonstrated in the keratin aggre-
gates of clone 9 hepatocytes. In addition, histone deacetyl-
ase 6, a microtubule-associated deacetylase, was identiWed
as a novel component of the keratin aggregates. Thus,
together with their ultrastructural appearance as randomly
oriented, organelle-free aggregates of keratin Wlaments, the
keratin aggregates in clone 9 hepatocytes correspond to
MBs. An imbalance in keratin 8 to18 with very low levels
of keratin 18 appears to be the underlying cause for their
formation. The formation of MBs was microtubule-depen-
dent although not depending on the activity of histone
deacetylase 6. Forskolin-induced MBs in clone 9 hepato-
cytes were reversible structures which disappeared upon
drug withdrawal. The MBs were not related to aggresomes
since overexpressed misfolded transgenic proteins were
undetectable in the keratin aggregates and no vimentin Wber
cage was detectable, both of which represent hallmarks of
aggresomes. Thus, cultured clone 9 hepatocytes are a useful
system to study further aspects of the pathobiology of MBs.
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Introduction
Intermediate Wlament (IF) proteins such as keratins and
vimentin are a major component of the cytoskeleton and
play an important role in establishing the structure and
integrity of the cell (Herrmann and Aebi 2004). They par-
ticipate in many important cellular processes such as cell
division, motility, cellular stress response, vesicular trans-
port and protect cells against mechanical injury.
Keratins, the largest family of the IF cytoskeletal pro-
teins, are divided into acidic keratin type I (K9–K20), and
neutral to basic keratin type II (K1–K8) and have a unique
tissue- and cell-speciWc expression (Moll et al. 2008). Epi-
thelial cells express at least one type I, and one type II of
keratin, forming non-covalently linked heteropolymers.
Adult hepatocytes are unique since they express only kera-
tin 8 and keratin 18 in a 1:1 stoichiometric ratio (Strnad
et al. 2008).
A wide variety of human diseases are associated with
alterations of the IF proteins (Omary et al. 2004). The
formation of Mallory bodies (MBs) in hepatocytes is
associated with alcoholic hepatitis and non-alcoholic
steatohepatitis (Strnad et al. 2008). MBs consist of aggre-
gates of hyperphosphorylated and/or poly-ubiquitinated
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294 Histochem Cell Biol (2009) 132:293–304keratin 8 and 18 (Yuan et al. 1995). Moreover, non-keratin
components such as hsp25, hsp70 and hsp90 (Zatloukal
et al. 2002; Riley et al. 2003), as well as ubiquitin and p62
(Stumptner et al. 2002; Zatloukal et al. 2002) are constitu-
ents of MBs. In mice, MBs can be induced by chronic
intoxication with griseofulvin (Denk et al. 1979), 3,5-dieth-
oxycarbonyl-1,4-dihydrocollidine (DDC) (Yokoo et al.
1982), okadaic acid (Yuan et al. 1998) and dexamethasone
(Yuan et al. 2000).
Recently, we reported (Hirano et al. 2002) that aggre-
gates of keratin Wlaments exhibiting typical structural
features of MBs existed in clone 9 rat hepatocytes stably
expressing the ER-retained T126M-aquaporin2 (AQP2).
Thus, we proposed that clone 9 rat hepatocyte cell cultures
represent a Wrst cell culture model for MB formation. The
mechanism of formation of MBs in humans and mice as
well as in the clone 9 hepatocytes is still incompletely
understood. However, an imbalance in the relative amounts
of keratin 8 and 18 as well as the keratin metabolism
appears to be an important factor for MB formation in liver
(Zatloukal et al. 2000; Nakamichi et al. 2005). It is also
unknown if in the T126M-AQP2 expressing clone 9 hepa-
tocytes, misfolded AQP2 is present in MBs.
Based on ultrastructural analyses, MBs in human alco-
holic liver disease have been divided into three subtypes
(Yokoo et al. 1972). MB subtype III was characterized by
the absence of a well-deWned Wlamentous structure and the
presence of highly electron dense granular or homoge-
neous inclusions, which resemble aggresomes (Johnston
et al. 1998; Garcia-Mata et al. 1999; Kopito and Sitia
2000). Aggresomes are cytoplasmic inclusion bodies
observed in several non-hepatic diseases such as in some
myopathies (Goebel 2003), in Alexander disease (Hagemann
et al. 2006), and in neurodegenerative diseases including
Alzheimer and Parkinson disease as well as in amyotro-
phic lateral sclerosis (Cairns et al. 2004). They are formed
when the proteolytic capacity of the proteasome is
exhausted and misfolded proteins aggregate in the cytosol
(Johnston et al. 1998; Garcia-Mata et al. 1999; Kopito and
Sitia 2000). They are composed of poly-ubiquitinated mis-
folded proteins that are surrounded by a cage of vimentin
Wbers (Johnston et al. 1998). Recently, histone deacetylase
6 (HDAC6), a microtubule-associated deacetylase, was
identiWed as a component of aggresomes. It acts to recruit
misfolded proteins to dynein motors for transport to aggre-
somes (Kawaguchi et al. 2003). Thus, this enzyme plays an
important role in the intracellular transport of misfolded
proteins.
In the present paper, we studied aspects of the mecha-
nism of MB formation in cultures of clone 9 hepatocytes,
and analyzed their composition in regard to the presence of
non-keratin components and established their relationship
to aggresomes.
Materials and methods
Antibodies and reagents
A guinea pig anti-p62 antibody (Zatloukal et al. 2002) was
kindly provided by Dr. Helmut Denk (Medical University
of Graz, Austria) and a rabbit anti-human HDAC6 antibody
(Hubbert et al. 2002) by Drs. Y. Kawaguchi and P. Y. Tao
(Duke University NJ, USA). Mouse monoclonal anti-
human Lu-5 Pan-Vertebrate conserved cytokeratin, and
Scriptaid were obtained from Biochemical (Augst, Switzer-
land), mouse monoclonal anti-keratin 8 and 18 antibodies
from Progene Biotechnik (Heidelberg, Germany), mouse
monoclonal anti-vimentin antibody from Neomarkers (Fre-
mont, CA, USA), mouse monoclonal anti- tubulin and
monoclonal anti- tublin from Sigma (Buchs, Switzerland)
and mouse monoclonal anti-multi-ubiquitin antibody from
MBL Co. (Nagoya, Japan). AYnity-puriWed rabbit poly-
clonal anti-rat aquaporin2 (AQP2) antibody was raised
against a synthetic peptide comprising the carboxy terminal
residues 254-271 of rat AQP2 cross-reactive with human
AQP2. Polyclonal anti-human 1-antitrypsin antibody was
purchased from DAKO (Zug, Switzerland), Alexa 488-con-
jugated (Fab)2 fragments of goat anti-mouse IgG and Alexa
546 conjugated (Fab)2 fragments of goat anti-rabbit IgG
from Molecular Probes (Eugene, OR, USA), and alkaline
phosphatase-conjugated goat anti-mouse IgG from Jackson
ImmunoResearch Laboratories, Inc. (West Grove, PA,
USA).
TRI reagent was purchased from Lucerna Chem (Luc-
erne, Switzerland), reverse transcription system from
Promega (Wallisellen, Switzerland), Taq DNA polymerase,
lipofectamine 2000, cell culture media and fetal bovine
serum from Invitrogen (Basel, Switzerland), and QIAquick
PCR-puriWcation Kit from QIAGEN (Basel, Switzerland).
Restriction enzymes, T4 DNA ligase and protease inhibitor
tablets were from Roche Diagnostics (Rotkreuz, Switzer-
land). Oligonucleotides were synthesized by Microsynth
(Balgach, Switzerland). Silencer siRNA construction kit
was from Ambion Inc. (Applied Biosystems, Rotkreuz,
Switzerland). Lactacystin, forskolin, griseofulvin, nocodaz-
ole and trichostatin A were obtained from Sigma (Buchs,
Switzerland), ALLN and MG132 from Calbiochem (Luc-
erne, Switzerland).
Cell lines and transfections
Cell lines used (Table 1) were obtained from American
Type Culture Collection (Manassas, VA) and grown in
recommended medium containing 10% fetal bovine serum
at 37°C in a 5 and 10% CO2 incubator, respectively. Clone
9 hepatocytes represent a heterogeneous cell population
regarding expression of keratin. Therefore, we established123
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clonal lines of clone 9 hepatocytes were used in all our
studies. Transfections with diVerent aquaporin2 (AQP2)-
and 1-antitrypsin-constructs were performed as described
previously (Hirano et al. 2002; Torossi et al. 2006). Clonal
cell lines were generated in 96-multiwell plates and
individual clones were tested for expression of AQP2 and
1-antitrypsin by immunoXuorescence.
Treatments of clone 9 rat hepatocytes
Clone 9 hepatocytes were incubated in medium containing
1, 2 and 5% ethanol, respectively, for 2 h, or with griseoful-
vin (10 nM) for 1–2 days, or with forskolin (10 M) for 6 h
at 37°C. Clone 9 hepatocytes stably expressing wild-type
AQP2, T126M-AQP2 or the Hong Kong variant of 1-anti-
trypsin were treated with the proteasome inhibitors MG132
(10 M), lactacystin (50 M) or ALLN (100 M) for 3 h up
to 24 h at 37°C. Clone 9 hepatocytes were treated with
MG132 (10 M) for 3 h and additionally with nocodazole
(10 M) or taxol (10 M) for 1, 2 and 3 h to depolymerize
microtubules. To inhibit histone deacetylase 6, cells were
pretreated with MG132 (see above) followed by tricostatin
A (1 or 10 M) or scriptaid (1 or 10 M) for 16 h at 37°C.
Confocal immunoXuorescence microscopy
Clone 9 rat hepatocytes grown on glass cover slips were
formaldehyde-Wxed and saponin-permeabilized as described
previously (Hirano et al. 2002). Single immunoXuorescence
for keratin using the pan cytokeratin Lu-5 monoclonal
antibody and for vimentin was performed (Hirano et al.
2002). Double immunoXuorescence for keratin in combina-
tion with either p62, poly-ubiquitin, vimentin, AQP2, 1-
antitrypsin or HDAC6 was performed according standard
protocol using appropriate Xuorescent secondary antibodies.
ImmunoXuorescence was observed and recorded with a
Leica Confocal Laser Scanning Microscope TSC PS2 using
the 100£ objective (1.4). The z-axis resolution of this
equipment was at maximum 300 nm per voxel and the x; y
settings were between 50 and 250 nm per voxel.
Electron microscopy and immunoelectron microscopy
For standard transmission electron microscopy, cells were
double aldehyde-Wxed followed by osmium tetroxide Wxa-
tion and Epon embedding (Hirano et al. 2002). For immu-
nogold labeling, cells were processed as described
previously (Hirano et al. 2002). BrieXy, they were Wxed in
situ 3% paraformaldehyde in PBS, mechanically removed
with a rubber policeman and resuspended in PBS contain-
ing 0.5% BSA. After centrifugation, cells were enclosed in
2% low-melting agarose and inWltrated with sucrose
(2.0 M) containing 15% polyvinol pyrrolidone (10 kDa) in
the presence of 1% paraformaldehyde. Ultrathin cryosec-
tions were prepared according to Tokuyasu (Tokuyasu
1978, 1980). For immunogold labeling, grids with attached
ultrathin cryosection were washed with PBS and condi-
tioned with PBS containing 1% BSA and 0.01% Tween 20.
Afterwards, grids were incubated either with anti-keratin 8
or anti-HDAC6 antibodies for 2 h at ambient temperature,
rinsed with PBS, and incubated with 8 nm gold-labeled
Table 1 Characterization of IF cytoskeletal proteins in various cell lines
a Cytokeratin was detected with the monoclonal anti-human Pan cytokeratin antibody Lu-5
b MB were induced by treatment of the cells with the proteasome inhibitor MG132 (10 M) for 3–24 h
c Presence of aggresomes was analyzed by imunoXuorescence for AQP2 or 1-antitrypsin
d Aggresomes in non-transfected CHO cells were formed following incubation with MG132 (40 M) for 3 h
Cell line Cytokeratina Vimentin MBb Aggresomesb
HEK 293 + + ¡
HeLa + + ¡
HT29 + + ¡
CaCo-2 + +
CHO-K1 ¡ + ¡ +d
Clone 9 hepatocytes #16 + + +
Clone 9 hepatocytes #14 + + +
Clone 9 hepatocytes #11 ¡ + ¡
Clone 9#16 expressing wt-AQP2 + + + ¡c
Clone 9#16 expressing T126M-AQP2 + + + ¡c
Clone 9#16 expressing A1AT (HK) + + + ¡c
CHO-K1 expressing T126M-AQP2 ¡ + ¡ ¡c
CHO-K1 expressing A1AT (HK) ¡ + ¡ ¡c123
296 Histochem Cell Biol (2009) 132:293–304goat anti-mouse IgG for 1 h. For double-labeling experi-
ments, cryosections were simultaneously incubated with
mouse anti-keratin 8 and guinea pig anti-p62 antibodies,
followed by 12 and 8 nm gold-labeled appropriate second-
ary antibodies, respectively.
RT-PCR
For the detection of keratin 8/18 mRNA and rat HDAC6
mRNA, RT-PCR was performed. Total RNA isolated from
rat liver or from clone 9 hepatocytes was reverse tran-
scribed by AMV reverse transcriptase using random prim-
ers. In the subsequent PCR ampliWcation, the following
speciWc oligonucleotides were used: kertin 8; forward
5-CAG AAA GCC AAG CAG GAC AT-3; reverse 5-CAA
TCT TCC CGA CCA CA-3, K18; forward 5-TTG CCG
CTG ATG ACT TTA GA-3; reverse 5-TCC AGT TCC
TCA CGG TTC TT-3, rat HDAC6; forward 5-CGG CCA
AGA TTC TTC TAC CAG G-3; reverse 5-CCG AAT
CTC AGC CCC CAT AAC T-3. As control, rat -actin
was ampliWed using the following primers: forward
5-CTG ATC CAC ATC TGC TGG AAG GTG G-3;
reverse 5-ACC TTC AAC ACC CCA GCC ATG TAC G-3.
The PCR products were resolved in 1% agarose gel con-
taining ethidium bromide.
Isolation of keratin Wlaments and Western blotting
Keratin Wlaments were isolated according to the protocol
of Gilmartin et al. (1984). BrieXy, clone 9 hepatocytes
were lysed in 1% Triton X-100, 25 mM Tris–HCl buVer
(pH 7.4) containing protease inhibitors. The buVer-insolu-
ble pellet was washed in the same buVer followed by incu-
bation in 1 M KCl, 25 mM Tris–HCl buVer (pH 7.4) at
37°C for 30 min. The insoluble pellet obtained after centri-
fugation at 12,000£g for 5 min was extracted in 9 M urea,
100 mM -mercaptoethanol, 25 mM Tris–HCl buVer (pH
7.4) containing protease inhibitors at 37°C for 30 min. Sol-
uble proteins (100 g protein/lane) were separated in 12%
SDS-polyacrylamide gels and transferred onto nitrocellu-
lose membranes using a semi-dry blotting apparatus
(Towbin et al. 1979). Western blot analysis was done with
anti-keratin 8 (diluted to 1 g/ml) and anti-keratin 18
(diluted to 1 g/ml) antibodies, respectively, followed by
alkaline phosphatase-conjugated secondary antibodies.
Color reaction was performed using nitro blue tetrazolium/
BCIP as substrates.
Inhibition of HDAC6 by RNA-mediated interference
For RNA-mediated interference, the following siRNA oli-
gonucleotides of rat HDAC6 were designed according to
the program provided by Ambion Inc. (Applied Biosystems,
Rotkreuz, Switzerland); forward: 5-AAA GAA TGA GTC
ACT GCA CCT GTC TC-3; reverse 5-AAT GCA GTG
ACT CAT CAT TCT CCT GTC TC-3; forward 5-AAA
GAC AGC TAA GGC ATT GCT CCT GTC TC-3;
reverse 5-AAA GCA ATG CCT TAG CTG TCT CCT
GTC TC-3. Clone 9 hepatocytes were plated on 35-mm2
Petri dishes to about 70% conXuency and transiently trans-
fected with 10 nM of siRNA using 3-l Lipofectamine
2000 reagent. The eVect of RNA interference for HDAC6
was determined by immunoXuorescence and by RT-PCR.
Results
Mallory body formation is not a general feature 
of keratin-positive cell lines
Recently, we reported an in vitro model for MB formation
using cultures of clone 9 rat hepatocytes stably expressing
ER-retained mutant T126M-aquaporin 2 (AQP2) (Hirano
et al. 2002). Additional proteasome inhibition with MG132
resulted in an increase in the number of keratin aggregates
in transfected clone 9 hepatocytes as well as in non-trans-
fected cells (Hirano et al. 2002). A detailed analysis by
conventional transmission electron microscopy of the kera-
tin immunoreactive aggregates (Hirano et al. 2002)
revealed Wne structural features typically observed in MB
in human alcoholic liver disease and griseofulvin-intoxi-
cated mice (Strnad et al. 2008). In Fig. 1, a clone 9 hepato-
cyte with a large perinuclear aggregate consisting of a
meshwork of loosely arranged, randomly oriented Wlaments
is observed. This aggregate of Wlaments is free of cellular
organelles (Fig. 1) and immunoreactive for keratin (see
below). Based on our previous Wndings, we asked whether
such keratin aggregates can be induced in other epithelial
cell lines. For this purpose, we Wrst investigated the keratin
expression in HEK 293 cells, HeLa cells, human colon car-
cinoma cells HT29 and Caco-2 cells and in CHO-K1 cells
(Table 1). We next tested whether aggregation of keratin
can be observed in the other keratin-positive cell lines.
Incubation of HeLa, HEK 293 and HT29 cells with the
proteasome inhibitor MG132 for 3–48 h resulted in a redis-
tribution of keratin Wlaments. However, no MB-like aggre-
gates of keratin Wlaments were detected (data not shown).
Thus, MB formation is not a general feature of cells
containing keratin Wlaments.
Keratin 18 is undedectable in clone 9 hepatocytes
To verify whether an imbalance in keratin 8 to 18 levels is
underlying the formation of keratin aggregates in the
cloned lines of clone 9 hepatocytes, the keratin 8 and 18
mRNA levels were determined in individual clones.123
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drastically lower than that of keratin 8 or undetectable, in
contrast to the reported 1:1 ratio for adult rat liver (Ku et al.
1999; Omary et al. 2002) (Fig. 2a). Consistently, only kera-
tin 8 but not keratin 18 was detected by Western blot in all
studied clonal lines of clone 9 hepatocytes (Fig. 2b). Like-
wise, keratin 8 immunolabeling was obtained by immuno-
Xuorescence (data not shown) and by immunoelectron
microscopy in keratin bundles (Fig. 2c) and in the large
aggregates of Wlaments of clone 9 hepatocytes (Fig. 2d). In
adult rat liver and in HeLa cells, both serving as a positive
control, keratin 8 and 18 were detected by Western blot
(Fig. 2b). Thus, the low expression of keratin 18 in clone 9
hepatocytes might be an important factor for the formation
of aggregates of keratin Wlaments corresponding to MBs.
Cellular stress induces Mallory bodies
in clone 9 rat hepatocytes
MBs are observed in human chronic alcoholic liver dis-
eases and can be induced in mice under conditions of
chronic intoxication (Denk et al. 1979, 2000; Omary et al.
2002; Zatloukal et al. 2004) and in clone 9 hepatocytes by
expressing an ER-retained misfolded membrane protein,
T126M variant of AQP2 (Hirano et al. 2002; present in
Fig. 3a–c). Furthermore, we found that overexpression of
the ER-retained Hong Kong variant of 1-antitrypsin in
clone 9 hepatocytes (Torossi et al. 2006) induced MBs
(Fig. 3d, f). Hence, a misfolded membrane as well as a mis-
folded secretory protein can induce MB in clone 9 hepato-
cytes. We have tested other forms of cellular stress for their
capacity to induce MBs in clone 9 hepatocytes. After short
time incubation with 1 and 2% ethanol, respectively, a two
to fourfold increase of cells containing keratin aggregates
was observed (Fig. 4a). Trypan blue staining showed that
such a treatment had no eVect on cell viability. On the other
hand, treatment of clone 9 hepatocytes with griseofulvin,
used to induce MBs in mice liver (Denk et al. 1979), did
not result in the formation of keratin aggregates in clone 9
Fig. 1 A clone 9 hepatocyte containing a large perinuclear aggregate
of Wlaments (marked by arrowheads). Cellular organelles are exclud-
ed. N nucleus, bar 0.5 m
Fig. 2 Keratin 18 is undetect-
able in clone 9 hepatocytes. 
a RT-PCR ampliWcation was 
performed using RNA isolated 
from clonal keratin-positive 
clone 9 hepatocytes and rat liver 
and speciWc keratin 8 and keratin 
18 primers (see “Materials and 
methods”). b Western blot anal-
ysis of isolated keratin Wlaments 
from clonal keratin-positive 
clone 9 hepatocytes (C9), HeLa 
cells and rat liver (RL) using 
anti-keratin 8 and anti-keratin18 
antibodies. c, d Immunoelectron 
microscopic detection of keratin 
8 in keratin bundles (c) and in a 
MB (d) of clone 9 hepatocytes 
expressing T126M-AQP2. 
N nucleus, bars 200 nm (c, d)123
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cytes containing keratin aggregates increased approxi-
mately sixfold upon treatment with the proteasome
inhibitors MG132 (Fig. 4b), lactacystin or the tetrapeptide
ALLN (data not shown), indicating that MBs can be
induced when the proteasomal degradation of cellular pro-
teins is inhibited.
Mallory body formation in clone 9 hepatocytes is reversible
MBs are characterized by the accumulation of hyper-phos-
phorylated keratin Wlaments (Stumptner et al. 2000). For-
skolin is known to increase intracellular cAMP levels and
to trigger protein kinase (PKA) activities and has been
shown to facilitate the hyperphosphorylation of keratin Wla-
ments in colon carcinoma Caco-2 cells (Baricault et al.
1994). In clone 9 hepatocytes, the number of cells contain-
ing keratin aggregates was increased about Wvefold after
forskolin treatment (Fig. 4b). After removal of forskolin, a
time-dependent decrease in the number of keratin aggre-
gate-containing cells was observed (Fig. 5). Three hours
following forskolin removal, a redistribution of keratin Wla-
ments occurred and a keratin network undistinguishable
from that of non-treated cells developed. We could exclude
that the decrease in the number of MBs was due to a mitotic
increase of the cell number. Measuring the cell growth
kinetics gave similar values in the absence or presence of
forskolin (Fig. 5, inset) indicating that the decrease in the
number of MBs was signiWcant.
Mallory bodies in clone 9 hepatocytes contain p62 
and poly-ubiquitin
p62 and poly-ubiquitin are major non-keratin constituents
of MBs of chronic alcoholic liver disease in humans
(Zatloukal et al. 2002). We investigated whether they were
also present in the induced keratin aggregates of clone 9
hepatocytes. By double immunoXuorescence, p62 was
Fig. 3 Mallory bodies are 
induced but do not contain 
mutant AQP2 or Hong Kong 
variant of 1-antitrypsin. 
a–c Double confocal immuno-
Xuorescence labeling for keratin 
and AQP2 shows that MBs in 
clone 9 hepatocytes expressing 
T126M-AQP2 and treated with 
MG132 do not contain mutant 
AQP2. d–f Likewise, MBs in 
clone 9 hepatocytes over-
expressing the Hong Kong 
variant of 1-antitrypsin do not 
contain mutant 1-antitrypsin. 
(bars 10 m)
Fig. 4 Cellular stress induces 
Mallory bodies in clone 9 hepa-
tocytes. a Mallory bodies can be 
induced by culturing cells in the 
presence of ethanol for 2 h. 
b Treatment with the proteaso-
mal inhibitor MG132 (10 M) or 
with forskolin (10 M) for 3 h 
results in the formation of 
Mallory bodies. Mallory body 
formation was evaluated by 
immunoXuorescence for keratin 
(see “Materials and methods”) 
(mean § SD are based on at 
least Wve independent sets of 
experiments)123
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could be conWrmed by double immunogold labeling
(Fig. 6d, e). Furthermore, the keratin aggregates exhibited
immunoreactivity for poly-ubiquitin (Fig. 6f, h). On the
other hand, the IF-type vimentin (Table 1), regularly asso-
ciated with aggresomes, was not detected as a component
of the keratin aggregates of clone 9 hepatocytes (Fig. 6i–l).
Misfolded membrane and secretory proteins 
are not detectable in Mallory bodies
Wild-type and T126M-AQP2 were stably expressed in
keratin-positive clone 9 hepatocytes (Table 1) in the pres-
ence of the proteasome inhibitor MG132. Both wild-type
and mutant AQP2 were undetectable in MB by double
immunoXuorescence (Fig. 3a–c). Likewise, MBs induced
by expressing the Hong Kong variant of 1-antitrypsin, in
the presence of MG132 did not contain the misfolded pro-
tein (Fig. 3d–f). These data demonstrate that although
MBs in clone 9 hepatocytes can be induced by the expres-
sion of misfolded proteins, the aberrant transgenic pro-
teins are not contained in the MBs. Remarkably, under
our experimental conditions no aggresomes were formed
Fig. 5 Mallory bodies induced by forskolin are reversible. Clone 9
hepatocytes were incubated for 3 h in medium containing forskolin
(10 M) to induce MBs (time point 0). Afterwards, the cells were
washed and maintained in medium not supplemented with forskolin
for various time periods. The growth kinetics of control and forskolin-
treated cells were similar (inset). (At least three independent sets of
experiments were performed)
Fig. 6 Mallory bodies contain p62 and are positive for poly-ubiquitin.
a–c Double confocal immunoXuorescence microscopy demonstrates
presence of p62 in MBs of clone 9 hepatocytes expressing T126M-
AQP2. d, e Immunogold double labeling for keratin 8 (large gold par-
ticles) and p62 (small gold particles) in MBs of clone 9 hepatocytes
expressing T126M-AQP2. f–h MBs in clone 9 hepatocytes are positive
for poly-ubiquitin. i–l ImmunoXuorescence for vimentin indicates
exclusion of vimentin from the keratin positive MBs. Arrowhead indi-
cates a MB. Bars 10 m (c, h, l), 50 nm (d, e)123
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mutant AQP2 or the Hong Kong variant of 1-antitrypsin,
respectively (Table 1).
Histone deacetylase 6 is a component of Mallory bodies
Keratin and -tubulin are co-localized in clone 9 hepato-
cytes, indicating that the aggregation of keratin Wlaments
occurred at the microtubule organizing center (Schatten
2008). Treatment of clone 9 hepatocytes with the microtu-
bule-disrupting agents, nocodazole or taxol, changed the
distribution of keratin Wlaments dramatically. Furthermore,
the number of MBs in cells treated either with nocodazole
or taxol and in addition with MG132 was reduced as
compared to only MG132-treated cells (Fig. 7). These data
indicated that microtubule disrupting reagents prevent MB
formation. Recently, HDAC6 was identiWed as a compo-
nent of aggresomes. It acts to recruit misfolded protein
cargo to dynein motors for subsequent transport to aggre-
somes (Kawaguchi et al. 2003). To investigate whether
HDAC6 is a component of MBs in clone 9 hepatocytes,
double immunolabeling for HDAC6 and keratin was
performed. HDAC6 and keratin were co-localized in MBs
of clone 9 hepatocytes (Fig. 8a–c). By immunoelectron
microscopy, HDAC6 was also detectable in MBs (Fig. 8d).
Thus, we hypothesized that HDAC6 might act in the
recruitment of aggregated keratin Wlaments for MBs. How-
ever, inhibition of HDAC6 using trichostain A or scriptaid
(Su et al. 2000; Hubbert et al. 2002) did not reduce the
number of MBs in clone 9 hepatocytes (data not shown).
Similarly, the knock-down of rat HDAC6 with diVerent
siRNA constructs had no eVect on MB formation (Fig. 8e,
f). Thus, we concluded that HDAC6 is probably not
involved in the recruitment of keratin Wlaments in MBs.
Discussion
Mallory bodies are typically observed in humans with alco-
holic and non-alcoholic liver disease and are also present in
the hepatocytes of patients with steatohepatitis as well as in
hepatocellular carcinomas (Okamura 1976; Denk et al.
1979; French 1983), in experimental mice models (Denk
et al. 1979; Franke et al. 1979; Denk and Franke 1981;
Yuan et al. 1998; Yuan et al. 2000) and in clone 9 hepato-
cytes expressing an ER-retained misfolded polytope mem-
brane protein (Hirano et al. 2002). Although MBs are
important in the diagnosis of several liver disorders, the
mechanism of their formation is not fully understood. In the
present study, we used the clone 9 hepatocytes as a model
(Hirano et al. 2002) for MB formation in order to study
conditions leading to their formation, their turnover and
composition as well as their relationship with aggresomes.
We found that MB can be induced in clone 9 hepato-
cytes by various types of cellular stress such as proteasome
inhibition, overexpression of a misfolded secretory and a
membrane protein, and by treatment with various chemical
compounds. Under basal conditions, cells refold misfolded
proteins assisted by chaperones, or degrade them via the
ubiquitin-proteasome system (Brodsky and McCracken
1999). Our data demonstrated that the presence of mis-
folded proteins or experimental proteasome inhibition
causes formation of intracellular inclusion bodies typical of
MBs in clone 9 hepatocytes. Similarly, during in vivo
proteasome inhibition, an accumulation of keratin, poly-
ubiquitinated proteins and heat shock proteins was observed
in rats (Bardag-Gorce et al. 2004). Ethanol treatment of clone
9 hepatocytes induced MBs eYciently, which might be
either due to the decreased proteasome activity or by oxida-
tive stress caused by ethanol-metabolism species. Ethanol
Fig. 7 Nocodazole treatment 
prevents Mallory body forma-
tion. a MBs in clone 9 hepato-
cytes, induced after treatment 
with MG132. b Although 
MG132 and nocodazole treat-
ment dramatically changed the 
distribution of keratin Wlaments, 
MBs were not observed. c Time-
dependent decrease of MBs in 
clone 9 hepatocytes after noco-
dazole and MG132 treatment, 
reaching the number of non-
treated cells. Number of MBs 
induced after MG132 treatment 
was set as 100%123
Histochem Cell Biol (2009) 132:293–304 301treatment of transformed HepG2 cells for 24 h has been
shown to reduce the gene expression of the 26 S protea-
some subunit and to induce keratin 8 and 18 expression
(Bardag-Gorce et al. 2006). Forskolin which causes hyper-
phosphorylation of keratin Wlaments (Baricault et al. 1994)
induced MBs in clone 9 hepatocytes. It allowed us to
demonstrate that MB formation is a reversible process in
clone 9 hepatocytes. It was not unexpected that griseofulvin
did not induce inclusion bodies of the MB type in our cell
culture system since chronic intoxication of mice is a required
condition (Denk et al. 1979). Our data unequivocally
demonstrated that keratin 8 is the major component of the
inclusion bodies of clone 9 hepatocytes. They are
composed of a dense network of randomly oriented keratin
Wlaments and devoid of cytoplasmic organelles (Hirano
et al. 2002), which is the canonical Wne structural appear-
ance of MBs in alcoholic liver disease (Strnad et al. 2008).
By reverse transcription polymerase chain reaction analy-
ses a vast excess of keratin 8 mRNA over keratin 18 mRNA
in clone 9 hepatocytes was revealed and this was conWrmed
at the protein level by Western blot. However, despite lev-
els of keratin 18 often too low to be detectable by Western
blot, a keratin network is observed in clone 9 hepatocytes.
On the other hand, the low amount of K18 protein seems to
be an important pathogenic factor for MB formation in
clone 9 hepatocytes. An imbalance of keratin 8 and 18 has
been shown to dysregulate the keratin metabolism (Kulesh
and Oshima 1988; Kulesh et al. 1989) and to cause diseased
Fig. 8 Histone deacetylase 6 
(HDAC6) is a component of 
Mallory bodies. a–c Double 
confocal immunoXuorescence 
showed co-localization of 
keratin and HDAC6 in clone 9 
hepatocytes expressing T126M-
AQP2. d Immunogold labeling 
for HDAC6 in MBs. Ultrathin 
frozen section. e Knock down of 
HDAC6 in clone 9 hepatocytes 
by transfection with RNAi-
constructs. RT-PCR analysis 
showed an almost complete 
absence of HDAC6 mRNA 
(lanes 2 and 3). No change in 
HDAC6 expression was 
observed in non-transfected 
clone 9 hepatocytes (lane 1) or 
after transfection with control 
RNAi (lane 4). Rat -actin was 
used as control for RT-PCR. 
f QuantiWcation of the HDAC6 
knock down on the number of 
MBs in clone 9 hepatocytes 
induced by MG132. siRNA 
knock down had no eVect on the 
number of MBs (lanes 2, 3), 
alike the use of control RNAi 
(lane 4) (mean § SD are based 
of at least Wve independent sets 
of experiments). Bars 10 m (c), 
100 nm (d)123
302 Histochem Cell Biol (2009) 132:293–304states (Baribault et al. 1993; Baribault et al. 1994). More-
over, aged keratin 18 knock-out mice developed a distinct
liver pathology with keratin 8-positive MB-like aggregates
(Magin et al. 1998), while in keratin 8-null mice, no MBs
were detectable after chemical intoxication (Zatloukal et al.
2000). The importance of the keratin 8/18 stoichiometry
was also demonstrated using cultured hepatocytes. Overex-
pression of wild type or a mutant form of keratin18 resulted
in MB formation because of the tendency of keratin 18 to
aggregate, whereas co-expression of keratin 8 suppressed
this tendency (Nakamichi et al. 2002; Kumemura et al.
2004). Hence, dysregulated expression of keratin 18 or an
imbalance between keratin 8 and 18 seems to be a central
condition for MB formation.
The keratins 8 and18 in MBs of human alcoholic hepati-
tis and in mouse models carry several posttranslational
modiWcations including phosphorylation, acetylation,
cross-linking and ubiquitination (Denk et al. 1979, 2000;
Ohta et al. 1988; Zatloukal et al. 1992; Ku and Omary
2000). Phosphorylation appears to be an important modiW-
cation of keratins since it is involved in keratin Wlament
organization and interaction with binding proteins (Ku
et al. 1999; Omary et al. 2006). Consistent with these in
vivo observations, keratins in MBs of clone 9 hepatocytes
appear to be hyperphosphorylated and are poly-ubiquiti-
nated. Furthermore, we identiWed p62 (Zatloukal et al.
2002) in MBs of clone 9 hepatocytes. p62 can bind poly-
ubiquitinated proteins and targets them for degradation by
proteosomes or autophagy (Seibenhener et al. 2004;
Bjorkoy et al. 2005) and is involved in MB formation (Nan
et al. 2004). In conclusion, the MBs formed in the clone 9
hepatocyte cell culture system appear to be compositional
identical to those found in human alcoholic liver disease
and in animals induced by chronic intoxication.
MBs and aggresomes are cytoplasmic inclusion bodies
found under various diseased states. They are composed of
poly-ubiquinated insoluble aggregates of proteins, which
have escaped proteasomal degradation. Although it was
suggested that MBs found in chronic liver disease are
aggresomes (French et al. 2001; Bardag-Gorce et al. 2002;
Riley et al. 2002), we believe that they have to be distin-
guished from aggresomes. In contrast to aggresomes which
are composed of misfolded aggregated proteins surrounded
by a vimentin cage (Johnston et al. 1998), MB in clone 9
hepatocytes expressing misfolded AQP2 or 1-antitrypsin
was not only devoid of the overexpressed transgenic pro-
teins but also had no cage-like vimentin structure. From
this we conclude that MBs and aggresomes are diVerent
types of inclusion bodies. Despite, there are some common
features. Microtubles are involved in the formation of both
aggresomes (Johnston et al. 1998; Cardinale et al. 2001;
Kabore et al. 2001) and of MBs (present study). HDAC 6 is
a component of both types of inclusion bodies (Kawaguchi
et al. 2003; present study) but seems to be involved only in
the formation of aggresomes.
In summary, the keratin aggregates formed in clone 9
hepatocytes correspond to MBs based on their Wne structure
and protein composition. They can be induced by various
forms of cellular stress and are reversible. The present
study also demonstrated that MBs are inclusion bodies
diVerent from aggresomes.
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